Pharma Industry, Pharma News, Indian Pharmaceutical Company News, International Pharmaceutical Company News update
Business Today

Drug firm Cipla on Tuesday said it has received fresh notices from National Pharmaceutical Pricing Authority (NPPA) for Rs 73.16 crore for overpricing of two drugs.

The firm's Bollaram manufacturing facility produces active pharmaceutical ingredients. Police said the victims at the company's facility were on night duty.
As part of the deal, Reckitt will buy 63 per cent stake of emerging markets private equity investor Actis, Sequoia Capital and that of the remaining shareholders.
Vishal Bali has spent 19 years running the Wockhardt Hospitals Group in India, until acquisition of its substantive assets (10 Hospitals) by Fortis in 2009.
During the quarter ended September 30, the company's income from operations stood at Rs 210.65 crore, compared to Rs 174.95 crore in the same period last year.
The 913.5-million rand order bagged by Sonke Pharmaceuticals is a part of a 4.28 billion rand national anti-retroviral (ARV) tender floated by the African government.
Both India and China are expected to propel the global pharma market to Rs 5.13 lakh crore ($1.1 trillion) by 2014.

The company shareholders, through a postal ballot, had approved the buy back of 4.18 crore shares of the firm from shareholders on a proportionate basis.
The drug major posted a net profit of Rs 312.8 crore for the quarter ended September 30, against the Rs 116.6 crore in the corresponding period last year.